{"name":"Achaogen","permalink":"achaogen","crunchbase_url":"http://www.crunchbase.com/company/achaogen","homepage_url":"http://www.achaogen.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"biopharma, anti-bacteria","alias_list":"","email_address":"","phone_number":"","description":"","created_at":"Thu Apr 08 04:27:23 UTC 2010","updated_at":"Mon Sep 06 06:24:54 UTC 2010","overview":"<p>Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The companyâ€™s most advanced drug candidate, ACHN-490, has demonstrated a positive safety and dosing profile in Phase 1 clinical testing and displayed broad spectrum efficacy in preclinical studies against systemic infections caused by multi-drug resistant (MDR) Gram-negative bacteria (e.g., E. coli, K. pneumoniae, and P. aeruginosa) and MRSA. In addition, the company is pursuing preclinical programs in several other areas of interest to combat the global emergence of bacterial resistance.</p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$82M","funding_rounds":[{"round_code":"c","source_url":"http://www.pr-inside.com/achaogen-completes-56-million-series-c-r1817734.htm","source_description":"Achaogen Completes $56 Million Series C Financing ","raised_amount":56000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"Frazier Healthcare Ventures","permalink":"frazier-healthcare-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/2779/32779v1-max-150x150.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-250x250.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Alta Partners","permalink":"alta-partners","image":{"available_sizes":[[[150,22],"assets/images/resized/0003/4978/34978v1-max-150x150.png"],[[168,25],"assets/images/resized/0003/4978/34978v1-max-250x250.png"],[[168,25],"assets/images/resized/0003/4978/34978v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"5AM Ventures","permalink":"5am-ventures","image":{"available_sizes":[[[149,105],"assets/images/resized/0004/7316/47316v1-max-150x150.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-250x250.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"ARCH Venture Partners","permalink":"arch-venture-partners","image":{"available_sizes":[[[131,71],"assets/images/resized/0003/6165/36165v1-max-150x150.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-250x250.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Venrock","permalink":"venrock","image":{"available_sizes":[[[150,52],"assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],[[351,123],"assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Wellcome Trust","permalink":"wellcome-trust","image":{"available_sizes":[[[150,23],"assets/images/resized/0002/9701/29701v1-max-150x150.png"],[[171,27],"assets/images/resized/0002/9701/29701v1-max-250x250.png"],[[171,27],"assets/images/resized/0002/9701/29701v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.achaogen.com/news/2/52","source_description":"Achaogen Closes Series B Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"5AM Ventures","permalink":"5am-ventures","image":{"available_sizes":[[[149,105],"assets/images/resized/0004/7316/47316v1-max-150x150.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-250x250.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"ARCH Venture Partners","permalink":"arch-venture-partners","image":{"available_sizes":[[[131,71],"assets/images/resized/0003/6165/36165v1-max-150x150.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-250x250.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Venrock","permalink":"venrock","image":{"available_sizes":[[[150,52],"assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],[[351,123],"assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"Headquarters","address1":"7000 Shoreline Court","address2":" Suite 371 ","zip_code":"94080","city":"South San Francisco ","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490","stoned_year":2010,"stoned_month":8,"stoned_day":30,"source_url":"http://www.achaogen.com/news/83/19","source_text":"","source_description":"Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Achaogen","permalink":"achaogen"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,110],"assets/images/resized/0008/4412/84412v1-max-150x150.jpg"],[[250,184],"assets/images/resized/0008/4412/84412v1-max-250x250.jpg"],[[450,332],"assets/images/resized/0008/4412/84412v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}